Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AdAstral Funds is a private venture studio and investment firm focused on building and backing science- and technology-driven companies addressing human and planetary health. The firm describes itself as advancing scientific ventures through an in-house lab, strategic partnerships with academic and government institutions, and access to large scientific and environmental datasets. Its model appears closer to a venture creation and impact-investing platform than an operating biotech or pharmaceutical developer. While it has exposure to health-related innovation, AdAstral Funds itself is not a therapeutic product company and does not appear to disclose an internal drug pipeline. The organization emphasizes ESG, SDG-aligned investing, and translational commercialization of science-based ventures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AdAstral Funds.